Published in Med Chem on January 01, 2014
Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science (1981) 9.64
Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry (2002) 3.82
Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev (1991) 3.07
Corticotropin-releasing factor, norepinephrine, and stress. Biol Psychiatry (1999) 2.39
CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats. Proc Natl Acad Sci U S A (2007) 2.01
Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats. Brain Res (1995) 1.43
Progress in corticotropin-releasing factor-1 antagonist development. Drug Discov Today (2010) 1.32
CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc Natl Acad Sci U S A (1996) 1.31
Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry (1995) 1.29
Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder. Depress Anxiety (2010) 1.24
Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology (1995) 1.22
CRF1 receptors as a therapeutic target for irritable bowel syndrome. Curr Pharm Des (2006) 1.15
Corticotropin-releasing factor-1 receptor involvement in behavioral neuroadaptation to ethanol: a urocortin1-independent mechanism. Proc Natl Acad Sci U S A (2008) 1.10
Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal models. Pharmacol Ther (2010) 1.06
Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats. Neurogastroenterol Motil (2005) 1.05
Elevated CSF CRF in suicide victims. Biol Psychiatry (1989) 1.01
Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone. Psychopharmacology (Berl) (1998) 0.99
First synthesis of 3-acetyl-2-aminothiophenes using the Gewald reaction. Molecules (2006) 0.99
Alanine scanning mutagenesis of the second extracellular loop of type 1 corticotropin-releasing factor receptor revealed residues critical for peptide binding. Mol Pharmacol (2009) 0.97
Marked suppression of gastric ulcerogenesis and intestinal responses to stress by a novel class of drugs. Mol Psychiatry (2002) 0.96
Synthesis and in vitro evaluation of the anticancer activity of novel fluorinated thiazolo[4, 5-d]pyrimidines. Arch Pharm (Weinheim) (2003) 0.95
Injection of Urocortin 3 into the ventromedial hypothalamus modulates feeding, blood glucose levels, and hypothalamic POMC gene expression but not the HPA axis. Am J Physiol Endocrinol Metab (2009) 0.93
Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation. J Rheumatol (2002) 0.92
Corticotropin releasing factor influences aggression and monoamines: modulation of attacks and retreats. Neuroscience (2008) 0.90
Corticotropin releasing factor (CRF) receptor modulators: progress and opportunities for new therapeutic agents. J Med Chem (2000) 0.90
Reductions in corticotropin releasing factor-like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy. Neurology (1987) 0.90
Potential uses of corticotropin-releasing hormone antagonists. Ann N Y Acad Sci (2006) 0.89
Antalarmin blockade of corticotropin releasing hormone-induced hypertension in rats. Brain Res (2000) 0.89
The corticotropin-releasing factor receptor: a novel target for the treatment of depression and anxiety-related disorders. Expert Opin Ther Targets (2005) 0.89
Inhibitory effect and transcriptional impact of berberine and evodiamine on human white preadipocyte differentiation. Fitoterapia (2009) 0.88
Thiazolo[4,5-d]pyrimidine thiones and -ones as corticotropin-releasing hormone (CRH-R1) receptor antagonists. Bioorg Med Chem Lett (1999) 0.88
[Corticotropin-releasing factor and anorexia nervosa: reactions of the hypothalamus-pituitary-adrenal axis to neurotropic stress]. Ann Endocrinol (Paris) (1994) 0.78
Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. J Biol Chem (2002) 2.87
Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation. Immunity (2004) 2.06
Development of a simple algorithm to guide the effective management of traumatic cardiac arrest. Resuscitation (2012) 1.53
Population structure, migration, and diversifying selection in the Netherlands. Eur J Hum Genet (2013) 1.47
The Young Netherlands Twin Register (YNTR): longitudinal twin and family studies in over 70,000 children. Twin Res Hum Genet (2012) 1.36
Use of the substituted cysteine accessibility method to study the structure and function of G protein-coupled receptors. Methods Enzymol (2002) 1.21
Short-term statin administration in hypercholesterolaemic rabbits resistant to postconditioning: effects on infarct size, endothelial nitric oxide synthase, and nitro-oxidative stress. Cardiovasc Res (2012) 1.15
Effects of glutathione reductase inhibition on cellular thiol redox state and related systems. Arch Biochem Biophys (2009) 1.01
Berberine inhibits adipogenesis in high-fat diet-induced obesity mice. Fitoterapia (2009) 1.00
Genotyping performance between saliva and blood-derived genomic DNAs on the DMET array: a comparison. PLoS One (2012) 0.99
Alanine scanning mutagenesis of the second extracellular loop of type 1 corticotropin-releasing factor receptor revealed residues critical for peptide binding. Mol Pharmacol (2009) 0.97
Lipid-lowering effect of berberine in human subjects and rats. Phytomedicine (2012) 0.95
De novo and inherited CNVs in MZ twin pairs selected for discordance and concordance on Attention Problems. Eur J Hum Genet (2012) 0.94
Polygenic scores associated with educational attainment in adults predict educational achievement and ADHD symptoms in children. Am J Med Genet B Neuropsychiatr Genet (2014) 0.93
Using a commercially available DNA extraction kit to obtain high quality human genomic DNA suitable for PCR and genotyping from 11-year-old saliva saturated cotton spit wads. BMC Res Notes (2008) 0.89
Inhibitory effect and transcriptional impact of berberine and evodiamine on human white preadipocyte differentiation. Fitoterapia (2009) 0.88
Associations among types of impulsivity, substance use problems and neurexin-3 polymorphisms. Drug Alcohol Depend (2011) 0.87
Twins, tissue, and time: an assessment of SNPs and CNVs. Twin Res Hum Genet (2012) 0.87
COMT Val158Met genotype as a risk factor for problem behaviors in youth. J Am Acad Child Adolesc Psychiatry (2010) 0.86
Berberine inhibits SREBP-1-related clozapine and risperidone induced adipogenesis in 3T3-L1 cells. Phytother Res (2010) 0.85
A prospective study of physician pre-hospital anaesthesia in trauma patients: oesophageal intubation, gross airway contamination and the 'quick look' airway assessment. BMC Anesthesiol (2013) 0.83
Association between autozygosity and major depression: stratification due to religious assortment. Behav Genet (2013) 0.83
G protein-coupled receptor signaling to Kir channels in Xenopus oocytes. Curr Pharm Biotechnol (2014) 0.81
Rational design, efficient syntheses and biological evaluation of N,N'-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers. Eur J Med Chem (2013) 0.81
A prospective study of the effects of breastfeeding and FADS2 polymorphisms on cognition and hyperactivity/attention problems. Am J Med Genet B Neuropsychiatr Genet (2013) 0.80
Mapping structural determinants within third intracellular loop that direct signaling specificity of type 1 corticotropin-releasing hormone receptor. J Biol Chem (2012) 0.80
Candidate gene associations with withdrawn behavior. J Child Psychol Psychiatry (2013) 0.80
Prehospital rapid-sequence intubation of patients with trauma with a Glasgow Coma Score of 13 or 14 and the subsequent incidence of intracranial pathology. Emerg Med J (2007) 0.80
Sarcophine-diol, a skin cancer chemopreventive agent, inhibits proliferation and stimulates apoptosis in mouse melanoma B₁₆F₁₀ cell line. Mar Drugs (2011) 0.79
A novel role of peripheral corticotropin-releasing hormone (CRH) on dermal fibroblasts. PLoS One (2011) 0.78
Evidence for downregulation of erythropoietin receptor in bone marrow erythroid cells of patients with chronic idiopathic neutropenia. Exp Hematol (2006) 0.77
Enhanced gene transfection efficiency by polyamidoamine (PAMAM) dendrimers modified with ornithine residues. Int J Pharm (2010) 0.77
Exploring the binding site crevice of a family B G protein-coupled receptor, the type 1 corticotropin releasing factor receptor. Mol Pharmacol (2010) 0.77
The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: a concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivatives. Eur J Med Chem (2012) 0.77
Evaluation of a stable gonadotropin-releasing hormone analog in mice for the treatment of endocrine disorders and prostate cancer. J Pharmacol Exp Ther (2010) 0.76
Maternal prenatal smoking and offspring emotional problems: no moderating effect of maternal or child 5-HTTLPR genotype. Am J Med Genet B Neuropsychiatr Genet (2012) 0.76
Estimation of Genetic Relationships Between Individuals Across Cohorts and Platforms: Application to Childhood Height. Behav Genet (2015) 0.76
An efficient synthetic method and theoretical calculations of olmesartan methyl ether: study of biological function of AT1 antagonism. Comb Chem High Throughput Screen (2014) 0.75
Role of Central and Peripheral CRH in Skin. Curr Mol Pharmacol (2016) 0.75
[Effect of Ganoderma triterpene on proliferation of dendritic cells from mouse spleen]. Zhong Yao Cai (2005) 0.75
The "homeostasis hormone" and its CRF₁ receptor. From structure to function. Hormones (Athens) (2012) 0.75
Practical translation of hemorrhage control techniques to the civilian trauma scene. Transfusion (2013) 0.75
Leveraging NMR and X-ray Data of the Free Ligands to Build Better Drugs Targeting Angiotensin II Type 1 G-Protein Coupled Receptor. Curr Med Chem (2016) 0.75
Rational drug design paradigms: the odyssey for designing better drugs. Comb Chem High Throughput Screen (2015) 0.75
The multi-faceted profile of Corticotropin-Releasing Factor (CRF) family of neuropeptides and of their receptors on the paracrine/local regulation of the inflammatory response. Curr Mol Pharmacol (2017) 0.75
Rationally designed cyclic analogues of luteinizing hormone-releasing hormone: enhanced enzymatic stability and biological properties. Eur J Med Chem (2012) 0.75
GnRH-Gemcitabine conjugates for the treatment of androgen-independent prostate cancer: pharmacokinetic enhancements combined with targeted drug delivery. Bioconjug Chem (2014) 0.75